Cary J. Claiborne

CIK: 0001370930

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

ADIL

ADIAL PHARMACEUTICALS, INC.

DirectorOfficer

NRSN

NeuroSense Therapeutics Ltd.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

ADIL
ADIAL PHARMACEUTICALS, INC.
Apr 7, 2026
Award(A)
Direct
38K shares-
ADIL
ADIAL PHARMACEUTICALS, INC.
May 29, 2025
Award(A)
Stock Option (Right to Buy)
Direct
138K shares-
ADIL
ADIAL PHARMACEUTICALS, INC.
Dec 5, 2024
Award(A)
Stock Option (Right to Buy)
Direct
350K shares-

		Type	Shares	Price		Ownership
Apr 7, 2026	ADIL ADIAL PHARMACEUTICALS, INC.	Award(A)	37,985	-	$0	Direct
May 29, 2025	ADIL ADIAL PHARMACEUTICALS, INC.	Award(A) Stock Option (Right to Buy)	138,000	-	-	Direct
Dec 5, 2024	ADIL ADIAL PHARMACEUTICALS, INC.	Award(A) Stock Option (Right to Buy)	350,000	-	-	Direct

1-3 of 3 transactions

About Claiborne Cary J

Claiborne Cary J (SEC CIK 0001370930) files insider reports with the SEC as Chief Executive Officer of ADIAL PHARMACEUTICALS, INC. (ADIL) and Director of NeuroSense Therapeutics Ltd. (NRSN).

Signal8 holds 4 ownership filings by Claiborne Cary J (1 Form 3, 3 Form 4), filed between Dec 5, 2024 and Apr 9, 2026. Those filings report 3 transactions, from Dec 5, 2024 to Apr 7, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Claiborne Cary J's filings is in GLEN ALLEN, VA.

Recent filings by Claiborne Cary J

Apr 7, 2026: Grant or award of ADIL shares (Form 4, code A).
May 29, 2025: Grant or award of ADIL derivative securities (Form 4, code A).
Dec 5, 2024: Grant or award of ADIL derivative securities (Form 4, code A).

Other insiders filing for ADIAL PHARMACEUTICALS, INC. (ADIL)

Davidson Matt, President and CEO
Saiki Julie, Chief Strategy Officer
Economides Vassiliki, Chief Financial Officer
Young Wendy B., Director
Coastlands Capital LP, 10% Owner
Goodman Tony, Chief Operating Officer

How to read Form 4 transaction codes